Further business development activities will kick off early in 2024 as members of our team fly to San Francisco to attend the Biotech Showcase and meet companies attending the J.P. Morgan 42nd Annual Healthcare Conference. 8th of Jan.
Next week hopefully we will hear something. I expect that they'll want to attend the conference with something solid to present. Most likely that recruitment is at x% and dosing will begin in x weeks.
Shareholder Email 19 December 2023, page-7
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $300 | 150K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 45915644 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 46231350 | 28 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |